Clinical Trial Update: A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Luminate in inducing posterior vitreous detachment for non-proliferative diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• Luminate

Snippet

Sponsor: Allegro Ophthalmics, LLC | Conditions: Non-Proliferative Diabetic Retinopathy | Phase 2 | Status: COMPLETED